Search
for
Sort by
Research 31–60 of 1000+
- Study on the Efficacy of Rosemary in Treating Hair Fall and Promoting Hair Growth
- Hormonal contraceptives: pharmacology tailored to women's health
- The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men
- Unraveling the Therapeutic Potential of Miracle Plant ‘Aftimoon’ in Disease Prevention and Treatment: A Comprehensive Review
- Potential herbs for treatment of dandruff: A review
- Acne in the adult female patient: a practical approach
- Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Green hair discoloration due to selenium sulfide
- Menopausal Acne – Challenges And Solutions
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Multiple minute digitate hyperkeratosis
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- COVID‐19, androgens, and androgenic alopecia
- Immunosuppressive therapy in autoimmune disease — A review
- Current and future pharmacotherapy for alopecia areata
- PHILADELPHIA DERMATOLOGICAL SOCIETY
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- SOWBHAGYA CHUNDI LEGIYAM, A SIDDHA FORMULATION FOR THE HEALTH OF PUERPERAL WOMEN: A REVIEW
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Interventions for morphea
- Dermatosis associated with menopause
- Hair loss
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Hair Disorders
- MICRO-URZĄDZENIA, BEZPRZEWODOWE KAPSUŁKI, MAPY, STYMULATORY I ROZRUSZNIKI STOSOWANE DO DIAGNOSTYKI I LECZENIA ZABURZEŃ MOTORYKI PRZEWODU POKARMOWEGO
- General Dermatology
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system